| Theme | Treatment for children, pregnant women and elderly patients with IBD | |
|---|---|---|
| Title | Current practices in guidance, management and nursing of pregnant women or women wishing to become pregnant who have inflammatory bowel diseases | |
| Publish Date | 2017/03 | |
| Author | Reiko Kunisaki | Inflammatory Bowel Disease Center, Yokohama City University Medical Center |
| Author | Haruka Otake | Inflammatory Bowel Disease Center, Yokohama City University Medical Center |
| Author | Masafumi Nishio | Inflammatory Bowel Disease Center, Yokohama City University Medical Center |
| Author | Tsuyoshi Ogashiwa | Inflammatory Bowel Disease Center, Yokohama City University Medical Center |
| Author | Hideaki Kimura | Inflammatory Bowel Disease Center, Yokohama City University Medical Center |
| Author | Madoka Nakagawa | Inflammatory Bowel Disease Center, Yokohama City University Medical Center / Nursing Department, Yokohama City University Medical Center |
| Author | Noriko Sorita | Nursing Department, Yokohama City University Medical Center / Perinatal Center for Maternity and Neonate, Yokohama City University Medical Center |
| Author | Shigeru Aoki | Perinatal Center for Maternity and Neonate, Yokohama City University Medical Center |
| Author | Kazuo Seki | Perinatal Center for Maternity and Neonate, Yokohama City University Medical Center |
| [ Summary ] | Inflammatory bowel diseases (IBDs) have a high prevalence among young individuals, giving rise to many reproductive issues. In accordance with recent data, mainly reported from Western countries, IBD itself does not increase adverse pregnancy outcomes and most drugs used in the treatment of IBD pose low risk to pregnancy. When explaining the pros and cons of treatment medication during pregnancy, it is important to not only emphasize the effect of the medication on the child, but also sufficiently explain the benefit obtained by continuing the treatment and the disadvantage of treatment discontinuation. The explanation is delayed when it is given after pregnancy and should be given to patients of reproductive age during consultations. As discrepancies in the practices of medical staff cause uneasiness in patients, in facilities that deal with IBD merger pregnancies, medical staffs assigned to digestive disease, obstetric, and pediatric cases have opportunities for joint study sessions in advance and can share desirable information. | |